Toggle navigation
Home
Search
Services
Blog
Contact
About
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
McCrae, Keith R.
Cleveland Clinic Lerner, Cleveland, OH, United States
Search 57 grants from Keith McCrae
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Function of MTG16/ETO2 in acute leukemia
NRF1 in Oxidative Stress
Notch Signaling and T Cell Fate
Carcinogen Resistance - Regulation of Carcinogen Efflux by Dietary Factors
Gating of the CFTR Cl Channel by Atp Hydrolysis
Recently added grants:
Characterization GPR83 and identification of small molecule ligands targeting this receptor for the treatment of substance use disorders.
Developing an intervention to improve quality of myocardial infarction care in northern Tanzania
Novel cellular markers of drug-mediated calcium signaling in astrocytes
New reporter system for spatiotemporal visualization of Toxoplasma gondii growth and development
Mentoring Patient-Oriented Research to Promote ARDS Precision Medicine
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Cooperative Agreement Phase II (UH3)
Project #
4UH3HL140097-02
Application #
10026357
Study Section
Clinical Trials Review Committee (CLTR)
Program Officer
Kindzelski, Andrei L
Project Start
2020-03-15
Project End
2024-02-29
Budget Start
2020-03-15
Budget End
2021-02-28
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Comments
Be the first to comment on Keith McCrae's grant